PD-1 on immature and PD-1 ligands on migratory human langerhans cells regulate antigen-presenting cell activity

Journal of Investigative Dermatology

Volumn 130, Issue 9, 2010, Pages 2222-2230

  Pẽa Cruz, Victor ^a   McDonough, Sean M ^a   Diaz Griffero, Felipe ^b   Crum, Christopher P ^c   Carrasco, Ruben D ^a   Freeman, Gordon J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; TOLL LIKE RECEPTOR 2;

ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVITY; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LANGERHANS CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; APOPTOSIS REGULATORY PROTEINS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL MOVEMENT; CYTOKINES; HUMANS; IMMUNOGLOBULINS; IMMUNOPHENOTYPING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JURKAT CELLS; LANGERHANS CELLS; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; UP-REGULATION;

EID: 77955710639     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.127     Document Type: Article

References (49)

1. Ansari MJ, Salama AD, Chitnis T et al. (2003) The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 198:63-69
2. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245-252
3. Barber DL, Wherry EJ, Masopust D et al. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439:682-687
4. Blanco P, Palucka AK, Pascual V et al. (2008) Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 19:41-52
5. Bonifaz L, Bonnyay D, Mahnke K et al. (2002) Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 196:1627-1638
6. Brown JA, Dorfman DM, Ma FR et al. (2003) Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol 170:1257-1266
7. Chemnitz JM, Parry RV, Nichols KE et al. (2004) SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol 173:945-954
8. Day CL, Kaufmann DE, Kiepiela P et al. (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443:350-354
9. Diaz-Griffero F, Hoschander SA, Brojatsch J (2002) Endocytosis is a critical step in entry of subgroup B avian leukosis viruses. J Virol 76: 12866-12876
10. Dorfman DM, Brown JA, Shahsafaei A et al. (2006) Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmuno-blastic T-cell lymphoma. Am J Surg Pathol 30:802-810
11. Fife BT, Pauken KE, Eagar TN et al. (2009) Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat Immunol 10:1185-1192
12. Freeman GJ, Long AJ, Iwai Y et al. (2000) Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192:1027-1034
13. Freeman GJ, Wherry EJ, Ahmed R et al. (2006) Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J Exp Med 203:2223-2227
14. Gray P, Dunne A, Brikos C et al. (2006) MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction. J Biol Chem 281:10489-10495
15. Greenwald RJ, Freeman GJ, Sharpe AH (2005) The B7 family revisited. Annu Rev Immunol 23:515-548
16. Hawiger D, Inaba K, Dorsett Y et al. (2001) Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194:769-779
17. Igyarto BZ, Jenison MC, Dudda JC et al. (2009) Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and Langerhans cell-derived IL-10. J Immunol 183:5085-5093
18. Ishida M, Iwai Y, Tanaka Y et al. (2002) Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol Lett 84:57-62
19. Iwai Y, Terawaki S, Ikegawa M et al. (2003) PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med 198:39-50
20. Kaplan DH, Jenison MC, Saeland S et al. (2005) Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23:611-620
21. Kaplan DH, Kissenpfennig A, Clausen BE (2008) Insights into Langerhans cell function from Langerhans cell ablation models. Eur J Immunol 38:2369-2376
22. Keir ME, Liang SC, Guleria I et al. (2006) Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med 203:883-895
23. Kobayashi N, Karisola P, Pena-Cruz V et al. (2007) TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 27:927-940
24. Latchman Y, Wood CR, Chernova T et al. (2001) PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2:261-268
25. Liang SC, Latchman YE, Buhlmann JE et al. (2003) Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur J Immunol 33:2706-2716
26. Loser K, Mehling A, Loeser S et al. (2006) Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 12:1372-1379
27. MacLeod H, Bhasin N, Wetzler LM (2008) Role of protein tyrosine kinase and Erk1/2 activities in the Toll-like receptor 2-induced cellular activation of murine B cells by neisserial porin. Clin Vaccine Immunol 15:630-637
28. Medvedev AE, Piao W, Shoenfelt J et al. (2007) Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance. J Biol Chem 282:16042-16053
29. Merad M, Ginhoux F, Collin M (2008) Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 8:935-947
30. Morel Y, Schiano de Colella JM, Harrop J et al. (2000) Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT downregulates its own receptor. J Immunol 165:4397-4404
31. Niebuhr M, Lutat C, Sigel S et al. (2009) Impaired TLR-2 expression and TLR-2-mediated cytokine secretion in macrophages from patients with atopic dermatitis. Allergy 64:1580-1587
32. Obhrai JS, Oberbarnscheidt M, Zhang N et al. (2008) Langerhans cells are not required for efficient skin graft rejection. J Invest Dermatol 128:1950-1955
33. Okazaki T, Honjo T (2007) PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol 19:813-824
34. Peiser M, Koeck J, Kirschning CJ et al. (2008) Human Langerhans cells selectively activated via Toll-like receptor 2 agonists acquire migratory and CD4+T cell stimulatory capacity. J Leukoc Biol 83:1118-1127
35. Pena-Cruz V, Ito S, Oukka M et al. (2001) Extraction of human Langerhans cells: a method for isolation of epidermis-resident dendritic cells. J Immunol Methods 255:83-91
36. Raimondi G, Shufesky WJ, Tokita D et al. (2006) Regulated compartmenta-lization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells. J Immunol 176:2808-2816
37. Salama AD, Chitnis T, Imitola J et al. (2003) Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J Exp Med 198:71-78
38. Sheppard KA, Fitz LJ, Lee JM et al. (2004) PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta. FEBS Lett 574:37-41
39. Steinman RM, Hawiger D, Nussenzweig MC (2003) Tolerogenic dendritic cells. Annu Rev Immunol 21:685-711
40. Stoitzner P, Tripp CH, Douillard P etal. (2005) Migratory Langerhans cells in mouse lymph nodes in steady state and inflammation. J Invest Dermatol 125:116-125
41. Tamada K, Shimozaki K, Chapoval AI et al. (2000) LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 164:4105-4110
42. Vesely DL, Fish D, Shlomchik MJ et al. (2009) Langerhans cell deficiency impairs Ixodes scapularis suppression of Th1 responses in mice. Infect Immun 77:1881-1887
43. Wang B, Amerio P, Sauder DN (1999) Role of cytokines in epidermal Langerhans cell migration. J Leukoc Biol 66:33-39
44. Wang J, Yoshida T, Nakaki F etal. (2005) Establishment of NOD-Pdcd1\/\mice as an efficient animal model of type I diabetes. Proc Natl Acad Sci USA 102:11823-11828
45. Wiendl H, Mitsdoerffer M, Schneider D et al. (2003) Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies. FASEBJ 17:1892-1894
46. Yamazaki T, Akiba H, Iwai H etal. (2002) Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 169:5538-5545
47. Yao S, Wang S, Zhu Y et al. (2009) PD-1 on dendritic cells impedes innate immunity against bacterial infection. Blood 113:5811-5818
48. Youngnak-Piboonratanakit P, Tsushima F, Otsuki N et al. (2004) The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role. Immunol Lett 94:215-222
49. Zou W, Chen L (2008) Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol 8:467-477